German Consumer Durables Stock News

Q1 2026 earnings snapshot for Ernst Russ (XTRA:ERAG) Ernst Russ (XTRA:ERAG) has opened 2026 with Q1 revenue of €41.0 million and net income of €11.0 million, setting a fresh reference point for investors watching the stock at around €9.10. The company has seen quarterly revenue move from €74.2 million in Q1 2025 to €41.0 million in Q1 2026, while trailing twelve month net income sits at €59.8 million against €42.5 million two years ago. This gives helpful context for how the latest quarter...

Novem Group (XTRA:NVM) closed FY 2026 with fourth quarter revenue of €144.4 million and a net loss of €6.1 million, setting a mixed tone for the latest earnings snapshot. Over recent periods the company has seen quarterly revenue move from €137.964 million in Q4 2025 to €128.9 million in Q1 2026, €125.576 million in Q2 2026, €117.9 million in Q3 2026 and then €144.4 million in Q4 2026. EPS shifted from €0.050251 in Q4 2025 to €0.36 in Q1 2026, €0.063987 in Q2 2026 and a loss of €0.02 in Q3...

Bayer plans to present 16 oncology abstracts at the 2026 ASCO Annual Meeting. Primary results from multiple cancer trials, including several Phase II studies, are set to be shared. The company will reveal head to head data from the Phase II ARACOG (AFT-47) trial of NUBEQA versus enzalutamide in advanced prostate cancer. Additional safety, efficacy, and subgroup analyses will cover a range of Bayer cancer therapies. Bayer (XTRA:BAYN), trading at around €36.53, has had mixed share...

SAP (XTRA:SAP) is back in focus after Sapphire 2026, where the company outlined its Autonomous Enterprise vision and launched its Business AI Platform, supported by partner endorsements and fresh recognition for SAP Signavio. See our latest analysis for SAP. The recent Autonomous Enterprise announcements and partner wins around SAP’s Business AI Platform have coincided with a 1-month share price return of 6.24%. However, the stock is still down 23.26% year to date and the 1-year total...

Interest in Siemens Healthineers (XTRA:SHL) has picked up after AiM Medical Robotics announced a collaboration that links its MRI-compatible neurosurgery robot with Siemens Healthineers’ MAGNETOM MRI scanners for real-time, image-guided procedures. See our latest analysis for Siemens Healthineers. Despite the robotics collaboration and recent investor outreach, including a UBS roadshow and portfolio review in India, Siemens Healthineers’ share price has been weak, with a year to date share...

Investors may be considering whether Bayerische Motoren Werke stock offers good value at today's price, or if the market is already fully reflecting its current story. The share price closed at €75.94, with a 7 day gain of 2.1%, but is down 4.3% over the past month and 21.2% year to date. The 1 year return sits at 2.3% and the 5 year return at 11.9%. These moves sit against a backdrop of ongoing attention on auto manufacturers, including debates about the balance between traditional...

The European market has recently shown a positive trend, with the pan-European STOXX Europe 600 Index climbing by 3.00%, driven by hopes of easing tensions in the Middle East. Amidst this backdrop, investors are increasingly exploring diverse opportunities within the market, including penny stocks. Though often seen as an outdated term, penny stocks still represent a viable investment avenue for those seeking smaller or newer companies with strong financial foundations and growth potential.

Uber has made an indicative cash offer to acquire Delivery Hero, which the company rejected. Reports suggest Uber is preparing a higher bid and has built a 19.5% stake in Delivery Hero. Delivery Hero's board is reviewing options that include a full sale or divestitures of core regions. Regulatory and antitrust scrutiny are emerging as key considerations for any potential transaction. Delivery Hero (XTRA:DHER) sits at the center of a fast evolving M&A story, with Uber moving from suitor to...

If you are wondering whether SAP at €151.80 offers value or risk at this point in the cycle, this article breaks down what the current price might be implying about the stock. The share price is broadly flat in the near term, with SAP up 0.6% over the past week and 2.0% over the past month. However, the stock is still down 24.8% year to date and down 41.2% over the past year, which may change how you think about its risk and return trade off. These moves sit against a backdrop of ongoing...

Earlier this month, Bayer announced that the U.S. FDA accepted a supplemental New Drug Application and granted Priority Review for Kerendia (finerenone) in adults with type 1 diabetes and chronic kidney disease, supported by Phase III FINE-ONE data showing significant reduction in urine albumin-to-creatinine ratio over six months alongside standard care. This move could broaden Kerendia’s use beyond its existing approvals in chronic kidney disease linked to type 2 diabetes and heart failure...

Verve Group (XTRA:VRV) opened 2026 with Q1 revenue of €146.0 million and a basic EPS loss of €0.01, as net income excluding extra items came in at a loss of €2.9 million. Over recent quarters, revenue has moved between €111.1 million and €208.2 million while basic EPS has ranged from a loss of €0.02 to a profit of €0.08. This highlights how quickly earnings can swing as margins shift. With revenue now at the higher end of its recent range but EPS back in loss making territory, the focus for...

AUTO1 Group SE recently reported profit growth but also disclosed a very large €487,000,000 cash burn over the last year, prompting analyst concerns about the lack of free cash flow and the quality of its earnings. At the same time, Goldman Sachs revealed it now controls about 9.20% of AUTO1 Group’s voting rights through shares and instruments, underscoring growing institutional attention just as questions emerge about how resilient those reported profits really are. We’ll now examine how...

Fresenius Medical Care: recent share performance in focus Fresenius Medical Care (XTRA:FME) has come back onto investor radars after a period of weaker share performance, with the stock down 7.1% year to date and 25.6% over the past year. See our latest analysis for Fresenius Medical Care. The recent drift in momentum, with a 30 day share price return of 3.94% and a 1 year total shareholder return decline of 25.61%, suggests sentiment has cooled after earlier gains over three years. If the...

Daimler Truck Holding stock reacts to recent performance data Daimler Truck Holding (XTRA:DTG) has come into focus after fresh performance data highlighted a mixed return profile, with the stock up over the past year but down over the past month and past 3 months. See our latest analysis for Daimler Truck Holding. At a share price of €41.68, Daimler Truck Holding shows a 7 day share price return of 6.57% but is down 5.27% over 30 days, while the 1 year total shareholder return of 15.45% and 3...

Volkswagen (XTRA:VOW3) stock continues to draw attention after recent trading, with the shares last closing at €90.50. Investors are weighing this price against the company’s earnings profile and multi-brand global footprint. See our latest analysis for Volkswagen. Recent trading has been mixed, with a 7 day share price return of 3.29% but a year to date share price return down 14.98%, while the 1 year total shareholder return has declined 5.18%. This suggests that momentum has softened...

If you are wondering whether Mercedes-Benz Group is attractively priced or not, the stock offers plenty of data points to test what you are really paying for. The share price recently closed at €50.92, with returns of 2.8% over the past 7 days, 2.3% over the past 30 days, a decline of 17.8% year to date, and a 5.6% gain over the past year. Together, these figures present a mixed picture of sentiment. Recent coverage around Mercedes-Benz Group has focused on its position in the Auto industry...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The subdued stock price reaction suggests that M1 Kliniken AG's ( ETR:M12 ) strong earnings didn't offer any surprises...

Wondering whether Siemens at €272.55 is offering good value or asking too much for its growth story is exactly the question this article will help you tackle. The stock has recorded returns of 6.1% over the last week, 12.1% over the last month, 13.0% year to date and 25.9% over the last year, with longer term returns of 87.0% over three years and 129.6% over five years. These moves sit against a backdrop of ongoing coverage of Siemens as a major European industrial and technology player,...

LEG Immobilien (XTRA:LEG) is in focus as its stock approaches the May 28 ex-dividend date, drawing attention from income investors who are weighing the appeal of its relatively low payout against recent earnings trends. See our latest analysis for LEG Immobilien. Recent trading suggests interest has picked up ahead of the ex-dividend date. The stock has posted a 2.9% 7-day share price return, yet the 1-year total shareholder return is down 18.2%. This hints that recent momentum contrasts with...

Investors may be wondering whether Delivery Hero at €37.60 is still offering value after its recent run, or if most of the opportunity is already priced in. The stock has returned 20.7% over the past week, 92.8% over the past month, 64.8% year to date and 51.4% over the past year, while the 5-year return shows a decline of 66.6%. These moves have come alongside ongoing attention on Delivery Hero's position in food delivery and related services, as investors reassess how the business model...

Deutsche Lufthansa (XTRA:LHA) has appointed Dr. Johannes Teyssen as chair of its supervisory board. The appointment brings in leadership experience from his prior executive roles, including at BP. This change marks a fresh corporate governance development for the airline group. For investors watching XTRA:LHA, the change at the top of the supervisory board comes as the stock trades around €8.172. Over the past month, the share price is up 12.7%, while the past year shows a 27.1% gain and a...

Siemens guidance confirmation and sector trends put stock in focus Siemens (XTRA:SIE) is back on investor radars after reaffirming its fiscal 2026 earnings guidance toward the upper half of its 6% to 8% group revenue growth range, alongside fresh half year results. See our latest analysis for Siemens. The reaffirmed 2026 guidance and recent half year earnings have coincided with a firm upswing in sentiment, with a 13.49% 1 month share price return and a 136.66% 5 year total shareholder return...

What sparked the latest move in AIXTRON? Recent enthusiasm for semiconductor equipment providers linked to global AI infrastructure build out has put AIXTRON (XTRA:AIXA) in focus. Investors are weighing its cash generation, zero debt position, and comparatively high P/E of 99. See our latest analysis for AIXTRON. That backdrop of AI infrastructure spending has coincided with strong momentum in AIXTRON’s stock, with a 30-day share price return of 15.95% and a 1-year total shareholder return of...